A Systematic Analysis of Nuclear Heat Shock Protein 90 (Hsp90) Reveals A

Total Page:16

File Type:pdf, Size:1020Kb

A Systematic Analysis of Nuclear Heat Shock Protein 90 (Hsp90) Reveals A Max Planck Institute of Immunobiology und Epigenetics Freiburg im Breisgau A systematic analysis of nuclear Heat Shock Protein 90 (Hsp90) reveals a novel transcriptional regulatory role mediated by its interaction with Host Cell Factor-1 (HCF-1) Inaugural-Dissertation to obtain the Doctoral Degree Faculty of Biology, Albert-Ludwigs-Universität Freiburg im Breisgau presented by Aneliya Antonova born in Bulgaria Freiburg im Breisgau, Germany March 2019 Dekanin: Prof. Dr. Wolfgang Driever Promotionsvorsitzender: Prof. Dr. Andreas Hiltbrunner Betreuer der Arbeit: Referent: Dr. Ritwick Sawarkar Koreferent: Prof. Dr. Rudolf Grosschedl Drittprüfer: Prof. Dr. Andreas Hecht Datum der mündlichen Prüfung: 27.05.2019 ii AFFIDAVIT I herewith declare that I have prepared the present work without any unallowed help from third parties and without the use of any aids beyond those given. All data and concepts taken either directly or indirectly from other sources are so indicated along with a notation of the source. In particular I have not made use of any paid assistance from exchange or consulting services (doctoral degree advisors or other persons). No one has received remuneration from me either directly or indirectly for work which is related to the content of the present dissertation. The work has not been submitted in this country or abroad to any other examination board in this or similar form. The provisions of the doctoral degree examination procedure of the faculty of Biology of the University of Freiburg are known to me. In particular I am aware that before the awarding of the final doctoral degree I am not entitled to use the title of Dr. Aneliya Antonova iii ACKNOWLEDGEMENTS First of all, I would like to express my gratitude to my supervisor Dr Ritwick Sawarkar for giving me the opportunity to carry out this challenging project in his lab. Thank you for guiding my way from a graduate to an independent and responsible scientist. I learned a lot from you! I am very grateful to all the former and present members of the lab for their scientific and moral support. Dear Parul, thank you for being such a supportive partner in that tough journey, a great friend and a valuable example. Barbara, Prashant, Fernando, Sergio, Erik, and Rebecca, I am glad I met every single one of you. I wish to thank the members of my thesis committee Prof Dr Rudolf Grosschedl and Prof Dr Andreas Hecht for their guidance. I would also like to acknowledge Dr Magdalena Baer- Rademacher, Dr Monika Lachner, Dr. Kyle Austin and Lisa Breitner, the coordinators of the International Max Planck Research School for Molecular and Cellular Biology (IMPRS- MCB) for always being there to help. I would like to thank my family and friends, who were so supportive and motivating during these years. My very special thanks go to my husband Nikolay Antonov who was always there to share my excitement in good times and hold my hand in bad days. Thank you for believing in me! And finally, thank you my little Thoma for being the sunshine in my days. I cannot wait to hear you saying “My mom is a scientist”. iv CONTENTS CONTENTS List of figures………………………………………………………………………………..viii List of tables…………………………………………………………………………………...x Abbreviations…………………………………………………………………………………xi Abstract……………………………………………………………………………………...xiii Zusammenfassung…………………………………………………………………………...xv CHAPTER I Systematic analysis of nuclear heat shock protein 90 (Hsp90) 1. Introduction ....................................................................................................................................... 1 1.1. Molecular chaperones ..................................................................................................... 1 1.2. Hsp90 .............................................................................................................................. 3 1.2.1. Structure and conformational cycle .......................................................................... 4 1.2.2. Function .................................................................................................................... 4 1.2.3. Regulation of Hsp90 ................................................................................................. 7 1.2.4. Chaperone cycle ..................................................................................................... 13 1.2.5. Hsp90 isoforms ....................................................................................................... 15 1.1.6. Hsp90 and cancer ................................................................................................... 16 1.2.7. Interactome studies ................................................................................................. 18 1.2.9. Nuclear Hsp90 ........................................................................................................ 23 1.2.9. Challenges and open questions ............................................................................... 27 2. Aims .............................................................................................................................................. 30 2.1. Nuclear Hsp90α and Hsp90β interactomes in human cells. .......................................... 30 2.2. Nuclear Hsp90α and Hsp90β PTMs. ............................................................................. 30 3. Materials and Methods .................................................................................................................. 31 3.1. Cell Culture and Cell Lines ........................................................................................... 31 3.2. Antibodies ..................................................................................................................... 31 3.3. Cell Fractionation .......................................................................................................... 31 3.4. SDS-PAGE .................................................................................................................... 33 3.5. Silver staining ................................................................................................................ 33 v CONTENTS 3.6. Western Blotting ........................................................................................................... 34 3.7. Nuclear Protein Affinity Purification coupled to Mass Spectrometry .......................... 34 3.7.1 Stable Cell Lines Generation ................................................................................... 34 3.7.2 Nuclear Protein Extract Preparation ........................................................................ 35 3.7.3 Protein Affinity Purification .................................................................................... 35 3.7.4. Protein Digestion and Mass Spectrometry Analysis .............................................. 36 3.8. SILAC labelling ............................................................................................................ 37 3.9. Di-Gly Immunoprecipitation ......................................................................................... 37 3.10. RNA isolation .............................................................................................................. 38 3.11. Immunofluorescence ................................................................................................... 38 3.12. Calcium Phosphate Transfection ................................................................................. 39 3.13. Synthetic Lethality Screen .......................................................................................... 39 4. Results ............................................................................................................................................. 40 4.1. Nuclear Hsp90 physical interactome investigated by affinity purification ................... 40 4.1.1. Nuclear Hsp90α interactions in normal growth conditions .................................... 42 4.1.2. Nuclear Hsp90β interactions in normal conditions ................................................ 51 4.1.3. Nuclear Hsp90α and Hsp90β interactions in stress conditions .............................. 53 4.2. Nuclear Hsp90 interactome investigated by revealing Hsp90-dependent ubiquitylated proteome ............................................................................................................................... 56 4.3. Hsp90 functional interactome investigation .................................................................. 72 4.4. Hsp90 PTMs .................................................................................................................. 73 4.5. Summary ....................................................................................................................... 75 5. Discussion and Outlook ................................................................................................................ 77 5.1. Nuclear Hsp90 interaction network ............................................................................... 77 5.1.1. Collaboration with nuclear protein folding and degradation machineries ............. 77 5.1.2. Role in gene expression regulation......................................................................... 80 5.1.3. RNA metabolism .................................................................................................... 81 5.1.3. Novel opportunities of anti-cancer therapies .......................................................... 84 5.1.4. Hsp90 during
Recommended publications
  • Recruitment of Ubiquitin-Activating Enzyme UBA1 to DNA by Poly(ADP-Ribose) Promotes ATR Signalling
    Published Online: 21 June, 2018 | Supp Info: http://doi.org/10.26508/lsa.201800096 Downloaded from life-science-alliance.org on 1 October, 2021 Research Article Recruitment of ubiquitin-activating enzyme UBA1 to DNA by poly(ADP-ribose) promotes ATR signalling Ramhari Kumbhar1, Sophie Vidal-Eychenie´ 1, Dimitrios-Georgios Kontopoulos2 , Marion Larroque3, Christian Larroque4, Jihane Basbous1,Sofia Kossida1,5, Cyril Ribeyre1 , Angelos Constantinou1 The DNA damage response (DDR) ensures cellular adaptation to Saldivar et al, 2017). Induction of the DDR triggers a cascade of genotoxic insults. In the crowded environment of the nucleus, the protein modifications by ADP-ribosylation, phosphorylation, SUMOylation, assembly of productive DDR complexes requires multiple protein ubiquitylation, acetylation, and methylation, which collectively modifications. How the apical E1 ubiquitin activation enzyme promote the assembly of DNA damage signalling and DNA repair UBA1 integrates spatially and temporally in the DDR remains proteins into discrete chromatin foci (Ciccia & Elledge, 2010; elusive. Using a human cell-free system, we show that poly(ADP- Dantuma & van Attikum, 2016). ribose) polymerase 1 promotes the recruitment of UBA1 to DNA. One of the earliest responses to DNA damage is the conjugation We find that the association of UBA1 with poly(ADP-ribosyl)ated by PARP1 of pADPr to substrate proteins, including itself, at DNA protein–DNA complexes is necessary for the phosphorylation rep- breaks and stalled replication forks (Caldecott et al, 1996; Bryant lication protein A and checkpoint kinase 1 by the serine/threonine et al, 2009; Langelier et al, 2011). PARP1 activity is induced by dis- protein kinase ataxia-telangiectasia and RAD3-related, a prototypal continuous DNA structures such as nicks, DSBs, and DNA cruciform response to DNA damage.
    [Show full text]
  • Analysis of Gene Expression Data for Gene Ontology
    ANALYSIS OF GENE EXPRESSION DATA FOR GENE ONTOLOGY BASED PROTEIN FUNCTION PREDICTION A Thesis Presented to The Graduate Faculty of The University of Akron In Partial Fulfillment of the Requirements for the Degree Master of Science Robert Daniel Macholan May 2011 ANALYSIS OF GENE EXPRESSION DATA FOR GENE ONTOLOGY BASED PROTEIN FUNCTION PREDICTION Robert Daniel Macholan Thesis Approved: Accepted: _______________________________ _______________________________ Advisor Department Chair Dr. Zhong-Hui Duan Dr. Chien-Chung Chan _______________________________ _______________________________ Committee Member Dean of the College Dr. Chien-Chung Chan Dr. Chand K. Midha _______________________________ _______________________________ Committee Member Dean of the Graduate School Dr. Yingcai Xiao Dr. George R. Newkome _______________________________ Date ii ABSTRACT A tremendous increase in genomic data has encouraged biologists to turn to bioinformatics in order to assist in its interpretation and processing. One of the present challenges that need to be overcome in order to understand this data more completely is the development of a reliable method to accurately predict the function of a protein from its genomic information. This study focuses on developing an effective algorithm for protein function prediction. The algorithm is based on proteins that have similar expression patterns. The similarity of the expression data is determined using a novel measure, the slope matrix. The slope matrix introduces a normalized method for the comparison of expression levels throughout a proteome. The algorithm is tested using real microarray gene expression data. Their functions are characterized using gene ontology annotations. The results of the case study indicate the protein function prediction algorithm developed is comparable to the prediction algorithms that are based on the annotations of homologous proteins.
    [Show full text]
  • Ubiquitination Is Not Omnipresent in Myeloid Leukemia Ramesh C
    Editorials Ubiquitination is not omnipresent in myeloid leukemia Ramesh C. Nayak1 and Jose A. Cancelas1,2 1Division of Experimental Hematology and Cancer Biology, Cincinnati Children’s Hospital Medical Center and 2Hoxworth Blood Center, University of Cincinnati Academic Health Center, Cincinnati, OH, USA E-mail: JOSE A. CANCELAS - [email protected] / [email protected] doi:10.3324/haematol.2019.224162 hronic myelogenous leukemia (CML) is a clonal tination of target proteins through their cognate E3 ubiq- biphasic hematopoietic disorder most frequently uitin ligases belonging to three different families (RING, Ccaused by the expression of the BCR-ABL fusion HERCT, RING-between-RING or RBR type E3).7 protein. The expression of BCR-ABL fusion protein with The ubiquitin conjugating enzymes including UBE2N constitutive and elevated tyrosine kinase activity is suffi- (UBC13) and UBE2C are over-expressed in a myriad of cient to induce transformation of hematopoietic stem tumors such as breast, pancreas, colon, prostate, lym- cells (HSC) and the development of CML.1 Despite the phoma, and ovarian carcinomas.8 Higher expression of introduction of tyrosine kinase inhibitors (TKI), the dis- UBE2A is associated with poor prognosis of hepatocellu- ease may progress from a manageable chronic phase to a lar cancer.9 In leukemia, bone marrow (BM) cells from clinically challenging blast crisis phase with a poor prog- pediatric acute lymphoblastic patients show higher levels nosis,2 in which myeloid or lymphoid blasts fail to differ- of UBE2Q2
    [Show full text]
  • HSF-1 Activates the Ubiquitin Proteasome System to Promote Non-Apoptotic
    HSF-1 Activates the Ubiquitin Proteasome System to Promote Non-Apoptotic Developmental Cell Death in C. elegans Maxime J. Kinet#, Jennifer A. Malin#, Mary C. Abraham, Elyse S. Blum, Melanie Silverman, Yun Lu, and Shai Shaham* Laboratory of Developmental Genetics The Rockefeller University 1230 York Avenue New York, NY 10065 USA #These authors contributed equally to this work *To whom correspondence should be addressed: Tel (212) 327-7126, Fax (212) 327- 7129, email [email protected] Kinet, Malin et al. Abstract Apoptosis is a prominent metazoan cell death form. Yet, mutations in apoptosis regulators cause only minor defects in vertebrate development, suggesting that another developmental cell death mechanism exists. While some non-apoptotic programs have been molecularly characterized, none appear to control developmental cell culling. Linker-cell-type death (LCD) is a morphologically conserved non-apoptotic cell death process operating in C. elegans and vertebrate development, and is therefore a compelling candidate process complementing apoptosis. However, the details of LCD execution are not known. Here we delineate a molecular-genetic pathway governing LCD in C. elegans. Redundant activities of antagonistic Wnt signals, a temporal control pathway, and MAPKK signaling control HSF-1, a conserved stress-activated transcription factor. Rather than protecting cells, HSF-1 promotes their demise by activating components of the ubiquitin proteasome system, including the E2 ligase LET- 70/UBE2D2 functioning with E3 components CUL-3, RBX-1, BTBD-2, and SIAH-1. Our studies uncover design similarities between LCD and developmental apoptosis, and provide testable predictions for analyzing LCD in vertebrates. 2 Kinet, Malin et al. Introduction Animal development and homeostasis are carefully tuned to balance cell proliferation and death.
    [Show full text]
  • Roles of Ubiquitination and Sumoylation in the Regulation of Angiogenesis
    Curr. Issues Mol. Biol. (2020) 35: 109-126. Roles of Ubiquitination and SUMOylation in the Regulation of Angiogenesis Andrea Rabellino1*, Cristina Andreani2 and Pier Paolo Scaglioni2 1QIMR Berghofer Medical Research Institute, Brisbane City, Queensland, Australia. 2Department of Internal Medicine, Hematology and Oncology; University of Cincinnati, Cincinnati, OH, USA. *Correspondence: [email protected] htps://doi.org/10.21775/cimb.035.109 Abstract is tumorigenesis-induced angiogenesis, during Te generation of new blood vessels from the which hypoxic and starved cancer cells activate existing vasculature is a dynamic and complex the molecular pathways involved in the formation mechanism known as angiogenesis. Angiogenesis of novel blood vessels, in order to supply nutri- occurs during the entire lifespan of vertebrates and ents and oxygen required for the tumour growth. participates in many physiological processes. Fur- Additionally, more than 70 diferent disorders have thermore, angiogenesis is also actively involved been associated to de novo angiogenesis including in many human diseases and disorders, including obesity, bacterial infections and AIDS (Carmeliet, cancer, obesity and infections. Several inter-con- 2003). nected molecular pathways regulate angiogenesis, At the molecular level, angiogenesis relays on and post-translational modifcations, such as phos- several pathways that cooperate in order to regulate phorylation, ubiquitination and SUMOylation, in a precise spatial and temporal order the process. tightly regulate these mechanisms and play a key In this context, post-translational modifcations role in the control of the process. Here, we describe (PTMs) play a central role in the regulation of these in detail the roles of ubiquitination and SUMOyla- events, infuencing the activation and stability of tion in the regulation of angiogenesis.
    [Show full text]
  • UBE2E1 (Ubch6) [Untagged] E2 – Ubiquitin Conjugating Enzyme
    UBE2E1 (UbcH6) [untagged] E2 – Ubiquitin Conjugating Enzyme Alternate Names: UbcH6, UbcH6, Ubiquitin conjugating enzyme UbcH6 Cat. No. 62-0019-100 Quantity: 100 µg Lot. No. 1462 Storage: -70˚C FOR RESEARCH USE ONLY NOT FOR USE IN HUMANS CERTIFICATE OF ANALYSIS Page 1 of 2 Background Physical Characteristics The enzymes of the ubiquitylation Species: human Protein Sequence: pathway play a pivotal role in a num- GPLGSPGIPGSTRAAAM SDDDSRAST ber of cellular processes including Source: E. coli expression SSSSSSSSNQQTEKETNTPKKKESKVSMSKN regulated and targeted proteasomal SKLLSTSAKRIQKELADITLDPPPNCSAGP degradation of substrate proteins. Quantity: 100 μg KGDNIYEWRSTILGPPGSVYEGGVFFLDIT FTPEYPFKPPKVTFRTRIYHCNINSQGVI Three classes of enzymes are in- Concentration: 1 mg/ml CLDILKDNWSPALTISKVLLSICSLLTDCNPAD volved in the process of ubiquitylation; PLVGSIATQYMTNRAEHDRMARQWTKRYAT activating enzymes (E1s), conjugating Formulation: 50 mM HEPES pH 7.5, enzymes (E2s) and protein ligases 150 mM sodium chloride, 2 mM The residues underlined remain after cleavage and removal (E3s). UBE2E1 is a member of the E2 dithiothreitol, 10% glycerol of the purification tag. ubiquitin-conjugating enzyme family UBE2E1 (regular text): Start bold italics (amino acid and cloning of the human gene was Molecular Weight: ~23 kDa residues 1-193) Accession number: AAH09139 first described by Nuber et al. (1996). UBE2E1 shares 74% sequence ho- Purity: >98% by InstantBlue™ SDS-PAGE mology with UBE2D1 and contains an Stability/Storage: 12 months at -70˚C; N-terminal extension of approximately aliquot as required 40 amino acids. A tumour suppressor candidate, tumour-suppressing sub- chromosomal transferable fragment Quality Assurance cDNA (TSSC5) is located in the re- gion of human chromosome 11p15.5 Purity: Protein Identification: linked with Beckwith-Wiedemann syn- 4-12% gradient SDS-PAGE Confirmed by mass spectrometry.
    [Show full text]
  • Proteomic Analysis of Thioredoxin-Targeted Proteins in Escherichia Coli
    Proteomic analysis of thioredoxin-targeted proteins in Escherichia coli Jaya K. Kumar, Stanley Tabor, and Charles C. Richardson* Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115 Contributed by Charles C. Richardson, December 29, 2003 Thioredoxin, a ubiquitous and evolutionarily conserved protein, mod- inactivates the apoptosis signaling kinase-1 (ASK-1) (18). This ulates the structure and activity of proteins involved in a spectrum of mode of regulation is incumbent on stringent protein interac- processes, such as gene expression, apoptosis, and the oxidative tions, because these thioredoxin-linked proteins do not contain stress response. Here, we present a comprehensive analysis of the regulatory cysteines. thioredoxin-linked Escherichia coli proteome by using tandem affinity To identify the regulatory pathways in which thioredoxin partic- purification and nanospray microcapillary tandem mass spectrome- ipates, we have characterized the thioredoxin-associated E. coli try. We have identified a total of 80 proteins associated with thiore- proteome. A genomic tandem affinity purification (TAP) tag (19) doxin, implicating the involvement of thioredoxin in at least 26 was appended to thioredoxin, and proteins associated with TAP- distinct cellular processes that include transcription regulation, cell tagged thioredoxin were identified by MS. division, energy transduction, and several biosynthetic pathways. We also found a number of proteins associated with thioredoxin that Methods either participate directly (SodA, HPI, and AhpC) or have key regula- TAP Tagging of trxA. The DNA sequence encoding the TAP tory functions (Fur and AcnB) in the detoxification of the cell. Tran- cassette from plasmid pFA6a-CTAP (20) was fused to the C scription factors NusG, OmpR, and RcsB, not considered to be under terminus of the sequence encoding thioredoxin in plasmid redox control, are also associated with thioredoxin.
    [Show full text]
  • Regulation of Canonical Wnt Signalling by the Ciliopathy Protein MKS1 and the E2
    bioRxiv preprint doi: https://doi.org/10.1101/2020.01.08.897959; this version posted March 28, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Regulation of canonical Wnt signalling by the ciliopathy protein MKS1 and the E2 ubiquitin-conjugating enzyme UBE2E1. Katarzyna Szymanska1, Karsten Boldt2, Clare V. Logan1, Matthew Adams1, Philip A. Robinson1+, Marius Ueffing2, Elton Zeqiraj3, Gabrielle Wheway1,4#, Colin A. Johnson1#* *corresponding author: [email protected] ORCID: 0000-0002-2979-8234 # joint last authors + deceased 1 Leeds Institute of Medical Research, School of Medicine, University of Leeds, Leeds, UK 2 Institute of Ophthalmic Research, Center for Ophthalmology, University of Tübingen, Tübingen, Germany 3 Astbury Centre for Structural Molecular Biology, School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, UK 4 Faculty of Medicine, University of Southampton, Human Development and Health, UK; University Hospital Southampton NHS Foundation Trust, UK 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.01.08.897959; this version posted March 28, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Abstract A functional primary cilium is essential for normal and regulated signalling. Primary ciliary defects cause a group of developmental conditions known as ciliopathies, but the precise mechanisms of signal regulation by the cilium remain unclear.
    [Show full text]
  • UBA1 (UBE1), Active Recombinant Full-Length Human Proteins Expressed in Sf9 Cells
    Catalog # Aliquot Size U201-380G-20 20 µg U201-380G-50 50 µg UBA1 (UBE1), Active Recombinant full-length human proteins expressed in Sf9 cells Catalog # U201-380G Lot # V2408-6 Product Description Specific Activity Full-length recombinant human UBA1 was expressed by baculovirus in Sf9 insect cells using an N-terminal GST tag. 2,800,000 The UBA1 gene accession number is NM_003334. 2,100,000 Gene Aliases 1,400,000 UBE1, CTD-2522E6.1, A1S9, A1S9T, A1ST, AMCX1, GXP1, 700,000 POC20, SMAX2, UBA1A, UBE1X Activity (RLU) 0 Formulation 0 20 40 60 80 Protein (ng) Recombinant proteins stored in 50mM Tris-HCl, pH 7.5, 150mM NaCl, 10mM glutathione, 0.1mM EDTA, 0.25mM The specific activity of UBA1 was determined to be 110 nmol DTT, 0.1mM PMSF, 25% glycerol. /min/mg as per activity assay protocol. Storage and Stability Purity Store product at –70oC. For optimal storage, aliquot target into smaller quantities after centrifugation and store at recommended temperature. For most favorable performance, avoid repeated handling and multiple The purity of UBA1 was determined freeze/thaw cycles. to be >95% by densitometry, approx. MW 145 kDa. Scientific Background Ubiquitin-activating enzyme 1 (UBA1) catalyzes the first step in ubiquitin conjugation to mark cellular proteins for degradation through the ubiquitin-proteasome system. UBA1 activates ubiquitin by first adenylating its C-terminal glycine residue with ATP, and thereafter linking this UBA1 (UBE1), Active residue to the side chain of a cysteine residue in E1, Recombinant full-length human protein expressed in Sf9 cells yielding a ubiquitin-E1 thioester and free AMP.
    [Show full text]
  • The Role of Ubiquitination in NF-Κb Signaling During Virus Infection
    viruses Review The Role of Ubiquitination in NF-κB Signaling during Virus Infection Kun Song and Shitao Li * Department of Microbiology and Immunology, Tulane University, New Orleans, LA 70112, USA; [email protected] * Correspondence: [email protected] Abstract: The nuclear factor κB (NF-κB) family are the master transcription factors that control cell proliferation, apoptosis, the expression of interferons and proinflammatory factors, and viral infection. During viral infection, host innate immune system senses viral products, such as viral nucleic acids, to activate innate defense pathways, including the NF-κB signaling axis, thereby inhibiting viral infection. In these NF-κB signaling pathways, diverse types of ubiquitination have been shown to participate in different steps of the signal cascades. Recent advances find that viruses also modulate the ubiquitination in NF-κB signaling pathways to activate viral gene expression or inhibit host NF-κB activation and inflammation, thereby facilitating viral infection. Understanding the role of ubiquitination in NF-κB signaling during viral infection will advance our knowledge of regulatory mechanisms of NF-κB signaling and pave the avenue for potential antiviral therapeutics. Thus, here we systematically review the ubiquitination in NF-κB signaling, delineate how viruses modulate the NF-κB signaling via ubiquitination and discuss the potential future directions. Keywords: NF-κB; polyubiquitination; linear ubiquitination; inflammation; host defense; viral infection Citation: Song, K.; Li, S. The Role of 1. Introduction Ubiquitination in NF-κB Signaling The nuclear factor κB (NF-κB) is a small family of five transcription factors, including during Virus Infection. Viruses 2021, RelA (also known as p65), RelB, c-Rel, p50 and p52 [1].
    [Show full text]
  • Exploring Intrinsically Disordered Proteins in Chlamydomonas
    www.nature.com/scientificreports Correction: Author Correction OPEN Exploring intrinsically disordered proteins in Chlamydomonas reinhardtii Received: 4 January 2018 Yizhi Zhang1, Hélène Launay 1, Antoine Schramm2, Régine Lebrun3 & Brigitte Gontero 1 Accepted: 26 March 2018 The content of intrinsically disordered protein (IDP) is related to organism complexity, evolution, and Published: xx xx xxxx regulation. In the Plantae, despite their high complexity, experimental investigation of IDP content is lacking. We identifed by mass spectrometry 682 heat-resistant proteins from the green alga, Chlamydomonas reinhardtii. Using a phosphoproteome database, we found that 331 of these proteins are targets of phosphorylation. We analyzed the fexibility propensity of the heat-resistant proteins and their specifc features as well as those of predicted IDPs from the same organism. Their mean percentage of disorder was about 20%. Most of the IDPs (~70%) were addressed to other compartments than mitochondrion and chloroplast. Their amino acid composition was biased compared to other classic IDPs. Their molecular functions were diverse; the predominant ones were nucleic acid binding and unfolded protein binding and the less abundant one was catalytic activity. The most represented proteins were ribosomal proteins, proteins associated to fagella, chaperones and histones. We also found CP12, the only experimental IDP from C. reinhardtii that is referenced in disordered protein database. This is the frst experimental investigation of IDPs in C. reinhardtii that also combines in silico analysis. Some biologically active proteins have no well-defned tertiary structure in their native state and are known as intrinsically disordered proteins (IDPs) while other proteins possess structural elements with some disordered (fexible) regions (IDRs)1–3.
    [Show full text]
  • Regulation of Human 69-Kda Choline Acetyltransferase Protein Stability and Function by Molecular Chaperones and the Ubiquitin- Proteasome System
    Western University Scholarship@Western Electronic Thesis and Dissertation Repository 1-25-2017 2:00 PM Regulation of Human 69-kDa Choline Acetyltransferase Protein Stability and Function by Molecular Chaperones and the Ubiquitin- Proteasome System Trevor M. Morey The University of Western Ontario Supervisor Rylett, R. Jane The University of Western Ontario Graduate Program in Physiology A thesis submitted in partial fulfillment of the equirr ements for the degree in Doctor of Philosophy © Trevor M. Morey 2017 Follow this and additional works at: https://ir.lib.uwo.ca/etd Part of the Molecular and Cellular Neuroscience Commons Recommended Citation Morey, Trevor M., "Regulation of Human 69-kDa Choline Acetyltransferase Protein Stability and Function by Molecular Chaperones and the Ubiquitin-Proteasome System" (2017). Electronic Thesis and Dissertation Repository. 5218. https://ir.lib.uwo.ca/etd/5218 This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of Scholarship@Western. For more information, please contact [email protected]. ABSTRACT: The enzyme choline acetyltransferase (ChAT) mediates synthesis of the neurotransmitter acetylcholine required for cholinergic neurotransmission. ChAT mutations are linked to congenital myasthenic syndrome (CMS), a rare neuromuscular disorder. One CMS-related mutation, V18M, reduces ChAT enzyme activity and cellular protein levels, and is located within a highly-conserved N-terminal proline-rich motif at residues 14PKLPVPP20. It is currently unknown if this motif regulates ChAT function. In this thesis, I demonstrate that disruption of this proline-rich motif in mouse cholinergic SN56 cells reduces both the protein levels and cellular enzymatic activity of mutated P17A/P19A- and V18M-ChAT.
    [Show full text]